(Q100661107)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33062953%20AND%20SRC:MED&resulttype=core&format=json

20 October 2020

title

Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33062953%20AND%20SRC:MED&resulttype=core&format=json

20 October 2020

1 reference

non-structural protein 5 [SARS-CoV-2]

1 reference

based on heuristic

inferred from abstract

pharmacology

1 reference

based on heuristic

inferred from abstract

author

Carleen Klumpp-Thomas

8

object named as

Carleen Klumpp-Thomas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33062953%20AND%20SRC:MED&resulttype=core&format=json

20 October 2020

author name string

Wei Zhu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33062953%20AND%20SRC:MED&resulttype=core&format=json

20 October 2020

Miao Xu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33062953%20AND%20SRC:MED&resulttype=core&format=json

20 October 2020

Catherine Z Chen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33062953%20AND%20SRC:MED&resulttype=core&format=json

20 October 2020

Hui Guo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33062953%20AND%20SRC:MED&resulttype=core&format=json

20 October 2020

Min Shen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33062953%20AND%20SRC:MED&resulttype=core&format=json

20 October 2020

Xin Hu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33062953%20AND%20SRC:MED&resulttype=core&format=json

20 October 2020

Paul Shinn

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33062953%20AND%20SRC:MED&resulttype=core&format=json

20 October 2020

Samuel G Michael

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33062953%20AND%20SRC:MED&resulttype=core&format=json

20 October 2020

Wei Zheng

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33062953%20AND%20SRC:MED&resulttype=core&format=json

20 October 2020

publication date

4 September 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33062953%20AND%20SRC:MED&resulttype=core&format=json

ACS pharmacology & translational science

20 October 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33062953%20AND%20SRC:MED&resulttype=core&format=json

20 October 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33062953%20AND%20SRC:MED&resulttype=core&format=json

20 October 2020

page(s)

1008-1016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33062953%20AND%20SRC:MED&resulttype=core&format=json

20 October 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33062953%20AND%20SRC:MED&resulttype=core&format=json

A new coronavirus associated with human respiratory disease in China

20 October 2020

cites work

1 reference

https://api.crossref.org/works/10.1021/ACSPTSCI.0C00108

Structure of Mpro from COVID-19 virus and discovery of its inhibitors

18 May 2021

1 reference

https://api.crossref.org/works/10.1021/ACSPTSCI.0C00108

Mechanisms and enzymes involved in SARS coronavirus genome expression

18 May 2021

1 reference

https://api.crossref.org/works/10.1021/ACSPTSCI.0C00108

Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors

18 May 2021

1 reference

https://api.crossref.org/works/10.1021/ACSPTSCI.0C00108

Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs

18 May 2021

1 reference

https://api.crossref.org/works/10.1021/ACSPTSCI.0C00108

Approved Antiviral Drugs over the Past 50 Years

18 May 2021

1 reference

https://api.crossref.org/works/10.1021/ACSPTSCI.0C00108

High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase

18 May 2021

1 reference

https://api.crossref.org/works/10.1021/ACSPTSCI.0C00108

Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries

18 May 2021

1 reference

https://api.crossref.org/works/10.1021/ACSPTSCI.0C00108

Mechanistic considerations in high-throughput screening

18 May 2021

1 reference

https://api.crossref.org/works/10.1021/ACSPTSCI.0C00108

Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease

18 May 2021

1 reference

https://api.crossref.org/works/10.1021/ACSPTSCI.0C00108

A grid algorithm for high throughput fitting of dose-response curve data

18 May 2021

1 reference

https://api.crossref.org/works/10.1021/ACSPTSCI.0C00108

An OpenData portal to share COVID-19 drug repurposing data in real time

18 May 2021

1 reference

https://api.crossref.org/works/10.1021/ACSPTSCI.0C00108

Coronaviruses - drug discovery and therapeutic options.

18 May 2021

1 reference

https://api.crossref.org/works/10.1021/ACSPTSCI.0C00108

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

18 May 2021

1 reference

https://api.crossref.org/works/10.1021/ACSPTSCI.0C00108

Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease

18 May 2021

1 reference

https://api.crossref.org/works/10.1021/ACSPTSCI.0C00108

Novel antibacterial compounds specifically targeting the essential WalR response regulator.

18 May 2021

1 reference

https://api.crossref.org/works/10.1021/ACSPTSCI.0C00108

Cobalamin inhibition of HIV-1 integrase and integration of HIV-1 DNA into cellular DNA.

18 May 2021

1 reference

https://api.crossref.org/works/10.1021/ACSPTSCI.0C00108

Differential effects on the hepatitis C virus (HCV) internal ribosome entry site by vitamin B12 and the HCV core protein

18 May 2021

1 reference

https://api.crossref.org/works/10.1021/ACSPTSCI.0C00108

Randomized study of three different doses of suramin administered with a fixed dosing schedule in patients with advanced prostate cancer: results of intergroup 0159, cancer and leukemia group B 9480.

18 May 2021

1 reference

https://api.crossref.org/works/10.1021/ACSPTSCI.0C00108

18 May 2021

1 reference

https://api.crossref.org/works/10.1021/ACSPTSCI.0C00108

Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry

18 May 2021

1 reference

https://api.crossref.org/works/10.1021/ACSPTSCI.0C00108

Structure-based inhibition of Norovirus RNA-dependent RNA polymerases

18 May 2021

1 reference

https://api.crossref.org/works/10.1021/ACSPTSCI.0C00108

Suramin inhibits chikungunya virus replication through multiple mechanisms

18 May 2021

1 reference

https://api.crossref.org/works/10.1021/ACSPTSCI.0C00108

Suramin inhibits SARS-CoV-2 infection in cell culture by interfering with early steps of the replication cycle

18 May 2021

1 reference

https://api.crossref.org/works/10.1021/ACSPTSCI.0C00108

Caspase inhibitor z-DEVD-fmk attenuates calpain and necrotic cell death in vitro and after traumatic brain injury

18 May 2021

1 reference

https://api.crossref.org/works/10.1021/ACSPTSCI.0C00108

The neuroprotective effects of z-DEVD.fmk, a caspase-3 inhibitor, on traumatic spinal cord injury in rats

18 May 2021

1 reference

https://api.crossref.org/works/10.1021/ACSPTSCI.0C00108

A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells

18 May 2021

1 reference

https://api.crossref.org/works/10.1021/ACSPTSCI.0C00108

HIV-1 Infection Primes Macrophages Through STAT Signaling to Promote Enhanced Inflammation and Viral Replication

18 May 2021

1 reference

https://api.crossref.org/works/10.1021/ACSPTSCI.0C00108

The NCATS Pharmaceutical Collection: a 10-year update

18 May 2021

1 reference

https://api.crossref.org/works/10.1021/ACSPTSCI.0C00108

The SARS-CoV-2 cytopathic effect is blocked with autophagy modulators

18 May 2021

1 reference

https://api.crossref.org/works/10.1021/ACSPTSCI.0C00108

Identifying SARS-CoV-2 entry inhibitors through drug repurposing screens of SARS-S and MERS-S pseudotyped particles

18 May 2021

1 reference

https://api.crossref.org/works/10.1021/ACSPTSCI.0C00108

18 May 2021

Identifiers

DOI

10.1021/ACSPTSCI.0C00108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33062953%20AND%20SRC:MED&resulttype=core&format=json

20 October 2020

1 reference